The American Society for Radiation Oncology (ASTRO) issued the following statement from Geraldine M. Jacobson, MD, MBA, MPH, FASTRO, Chair of the ASTRO Board of Directors, in response to the proposed 2024 Medicare Physician Fee Schedule (MPFS) released today: “Another year brings another round of cuts to radiation therapy services for people with cancer under the proposed Medicare fee schedule.”
Tag: Reimbursement
ASTRO submits comments to CMS: Stop the draconian cuts that will harm cancer patient care
The American Society for Radiation Oncology (ASTRO) submitted two comment letters to the Centers for Medicare and Medicaid Services (CMS) today urging the agency to reconsider policy changes that will result in $300 million in Medicare cuts for radiation therapy services starting January 1, 2022.
Legislation for Surprise Billing May Decrease In-Network Reimbursement
A new Harvey L. Neiman Health Policy Institute study, published in Radiology, reviewed the implications of unexpected out-of-network balance billing—commonly called surprise billing—on reimbursement for hospital-based specialties such as radiology. The analysis concluded that even physicians who never engaged in such billing practices may still be impacted by the No Surprises Act, which is due to take effect in 2022.
Geriatric Emergency Departments Associated with Lower Medicare Expenditures
As the U.S. population ages, more hospitals are implementing geriatric emergency department (GED) programs with specialized staff focused on transitional care for older adults. A new study finds that providing specialized geriatric emergency care results in lower Medicare expenditures up to $3,200 per beneficiary.
Falling Medicare Reimbursement Rates for Orthopaedic Trauma
The amount Medicare reimburses for orthopaedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Measuring Frailty More Accurately Predicts Cost of Care
A team of researchers identified a way to measure frailty using patients’ medical claims that more accurately predict costs-of-care, especially for clinicians with disproportionate shares of frail patients.